Ann: HMD Update & COVID-19 Opportunities Conference Call, page-83

First 83 Last

Share
Profile

Follow
Iknowyysh

3,237 Posts.

490

27/03/20

00:01

Post #: 43722785
Share

Originally posted by Alby118: ↑

disturbution deals and contract roll outs very soon!!!
Maternity telehealth company HeraMED (ASX: HMD)revealed this morning in a conference call it was in “advanced discussions” regarding the expedited commercial roll-out of its platform across the US, UK, Australia and Israel.
The company’s HeraCARE maternity telehealth platform enables health professionals to monitor pregnant women from their homes and includes the HeraBEAT foetal heart rate monitor and activity tracker.
HeraCARE also tracks blood pressure, weight gain and provides expectant mothers with the ability to join group discussions, speak to a remote midwife, and strengthen mental health via meditation, mood tracking and emotional discussion groups.

speaking in this morning’s conference call update, HeraMED chief executive officer and co-founder David Groberman said the rampant spread of COVID-19 globally and the critical need for pregnant women to self-isolate called for more rapid development of the company’s technology.
Health entities globally have pointed out the current need for telehealth services and a “comprehensive” home-based approach.

goverments have backed this call with Australian Minister for Health Greg Hunt issuing a media statement earlier this week claiming the Australian Government was working with the country’s critical health bodies to expand its telehealth response.
“As the coronavirus situation develops, we need to ensure we protect the vulnerable and it remains important regional Australians can access their regular medical services,” Mr Hunt said.
“To help ensure these services continue, the government is expanding access to telehealth services so vulnerable patients and doctors alike needn’t risk unnecessary human contact,” he added.
Using New York as an example HeraMED US general manager Alex Radke said it was now an epicentre for the COVID-19 crisis in the US.
He said medical professionals were taking a “very conservative” approach to pregnant women who have been asked to self-isolate and as a result.
Additionally, the government has encouraged pregnant women to take “critical steps” to avoid exposure and part of this is virtual consultations to avoid high risk doctors’ offices and hospitals.
Mr Groberman said as a result of the detrimental impact of COVID-19, “world leading” healthcare providers and insurance companies have contacted the HeraMED and engaged in “advanced” discussions regarding deployment of HeraCARE.
“HeraMED presents a unique and total solution that many are seeking out,” Mr Radke added

Expand

Just imagine how quickly the SP will rise once deals are announced. Given the current climate its safe to say they should be imminent.

HMD Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BOE

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

EBR

EBR Systems' heart pacing device on-target to reach the US market

SKS

SKS secures $20M for extension works on Melbourne data centre

There are more pages in this discussion • 40 more messages in this thread...

First 83 Last

Add HMD (ASX) to my watchlist

(20min delay)
Last 2.6¢		Change 0.000(0.00%)		Mkt cap ! $16.46M

Open	High	Low	Value	Volume
2.4¢	2.6¢	2.2¢	$10.98K	471.3K

Buyers (Bids)

No.	Vol.	Price($)
1	90207	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	156429	1

View Market Depth

No.	Vol.	Price($)
1	90207	0.022
4	2103971	0.020
1	26200	0.019
1	250000	0.018
2	1052007	0.017

Price($)	Vol.	No.
0.026	156429	1
0.027	150000	1
0.028	150000	1
0.030	875631	1
0.100	1000	1

Last trade - 16.10pm 04/09/2024 (20 minute delay)

HMD (ASX) Chart

Ann: HMD Update & COVID-19 Opportunities Conference Call, page-83

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

EBR Systems' heart pacing device on-target to reach the US market

SKS secures $20M for extension works on Melbourne data centre

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: HMD Update & COVID-19 Opportunities Conference Call, page-83

Top Stories

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

EBR Systems' heart pacing device on-target to reach the US market

SKS secures $20M for extension works on Melbourne data centre

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News